Suchergebnisse - "Ding, Jian"

PubPharm (84)

1

Characterization of LTr1 derived from cruciferous vegetables as a novel anti-glioma agent via inhibiting TrkA/PI3K/AKT pathway

enthalten in: Acta pharmacologica Sinica | 2023

von Song, Q. | Lin, L. | Chen, Y. | +8

2

Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations

enthalten in: Journal of medicinal chemistry | 2022

von Chen, H. | Lai, M. | Zhang, T. | +9

3

LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo

enthalten in: Cancer science | 2022

von Liu, Y. | Lai, M. | Li, S. | +20

4

The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer

enthalten in: Cancer biology & medicine | 2022

von He, T. | Gao, Y. | Fang, Y. | +5

5

Discovery and structure - activity relationship exploration of pyrazolo[1,5-a]pyrimidine derivatives as potent FLT3-ITD inhibitors

enthalten in: Bioorganic & medicinal chemistry | 2021

von Chen, Y. | Bai, G. | Li, Y. | +7

6

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2021

von Xia, L. | Liu, J. | Zheng, Z. | +6

CommentIn: Mol Ther. 2021 Oct 6;29(10):2896-2897. - PMID 34559988

7

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

enthalten in: Acta pharmacologica Sinica | 2021

von Xia, Z. | Ji, Y. | Sun, D. | +8

8

Synthesis of triazolotriazine derivatives as c-Met inhibitors

enthalten in: Molecular diversity | 2021

von Guo, Y. | Peng, X. | Ji, Y. | +5

9

LRTM1 promotes the differentiation of myoblast cells by negatively regulating the FGFR1 signaling pathway

enthalten in: Experimental cell research | 2020

von Li, H. | Zhou, Y. | Ding, J. | +7

10

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

enthalten in: Molecular cancer | 2020

von Zhang, T. | Qu, R. | Chan, S. | +18

ErratumIn: Mol Cancer. 2021 Aug 17;20(1):102. - PMID 34404402

1
2
3
4
5
6
7
8
9
Nächster »
[9]